NFTs contain phospho-tau, an established biomarker for AD, and tauopathy may be a driver for neuron loss in AD via necroptosis, possibly involving cofactors such as Transactive Response DNA-binding protein 43 (TDP-43) and Aβ91. Here, MAPT is linked to Alzheimer disease.